LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that its President and Chief Executive Officer, Safi Bahcall, Ph.D. received the Ernst & Young Entrepreneur Of The Year® 2008 Award in the Biotechnology/Pharmaceuticals category in New England. According to Ernst & Young LLP, the award recognizes outstanding entrepreneurs who are building and leading dynamic, growing businesses. Safi Bahcall was selected by an independent panel of judges, and the award was presented at a gala event at the Westin Boston Waterfront on Tuesday, June 24, 2008.
